Clinical Trial: Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)
Study Status: Completed
Recruit Status: RECRUITING
Condition: OSA
Study Type: INTERVENTIONAL
Official Title: Phase 3 Randomized Double-Blind Placebo-Controlled 6-month Parallel-Arm Study to Compare a Fixed Dose Combination of Aroxybutynin/Atomoxetine (AD109) to Placebo in Obstructive Sleep Apnea (SynAIR
Brief Summary:
This is a Phase 3 Randomized Double-Blind Placebo-Controlled 6-month Parallel-Arm Study to Compare a Fixed Dose Combination of AD109 to Placebo in Obstructive Sleep Apnea.
Read more